The nasal spray to ease intractable depression appears on the US market after decades without novel antidepressant treatments.

Fluoxetine dampened stress responses in zebrafish embryos exposed to the drug—and their descendants.

The compound, BCI-838, is already in human clinical trials as a possible treatment for depression.

Impairments in the production of neurotransmitters may lead to depression in some patients, preliminary results show, opening new avenues for research.

Beyond Biocentrism, The Sting of the Wild, The Birth of Anthropocene, and Ordinarily Well

Structural studies reveal how SSRI drugs bind to the human serotonin transporter.

An SSRI commonly prescribed to treat depression could help prevent the formation of Alzheimer’s disease-associated amyloid plaques.

Researchers show that lanicemine is an effective antidepressant without the adverse effects of the related hallucinogenic drug.